CSIMarket
 


Biotricity Inc   (BTCY)
Other Ticker:  
 

Biotricity Inc 's Working Capital Ratio

BTCY's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth

 


Biotricity Inc 's Current Assets grew by 19.61 % in the Q3 2024 sequentially, while Current Liabilities decreased, this led to improvement in Biotricity Inc 's Working Capital Ratio to 0.23, Working Capital Ratio remained below Biotricity Inc average.

Within Medical Equipment & Supplies industry 200 other companies have achieved higher Working Capital Ratio than Biotricity Inc in third quarter 2024. While Working Capital Ratio total ranking in the third quarter 2024 has deteriorated compared to the prior quarter from 4049 to 4142.

Explain Working Capital Ratio
How much Current Assetss BTCY´s has?
What are BTCY´s Current Liabilities?


BTCY Working Capital Ratio (Dec 31 2024)
Q3
(Sep 30 2024)
Q2
(Jun 30 2024)
Q1
(Mar 31 2024)
Q4
(Dec 31 2023)
Q3
Y / Y Current Liabilities Change 13.55 % 42.34 % 84.39 % 211.34 % 324.24 %
Y / Y Current Assets Change 23.62 % -7.64 % -13.26 % -6.75 % -41.76 %
Working Capital Ratio MRQ 0.23 0.19 0.2 0.2 0.21
BTCY's Total Ranking # 4142 # 4049 # 4110 # 3560 # 3863
Seq. Current Liabilities Change -1.62 % 4.42 % -9.34 % 21.91 % 23.32 %
Seq. Current Assets Change 19.61 % -0.72 % -8.42 % 13.68 % -10.64 %



Working Capital Ratio third quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 201
Healthcare Sector # 930
Overall Market # 4142


Working Capital Ratio Statistics
High Average Low
4.06 0.75 0.02
(Dec 31 2021)   (Dec 31 2016)




Financial Statements
Biotricity Inc 's Current Liabilities $ 21 Millions Visit BTCY's Balance sheet
Biotricity Inc 's Current Assets $ 5 Millions Visit BTCY's Balance sheet
Source of BTCY's Sales Visit BTCY's Sales by Geography


Cumulative Biotricity Inc 's Working Capital Ratio

BTCY's Working Capital Ratio for the trailling 12 Months

BTCY Working Capital Ratio

(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth 64.68 % 119.8 % 180.82 % 219.91 % 179.54 %
Y / Y Current Assets TTM Growth -2 % -19.86 % -37.68 % -53.54 % -66.02 %
Working Capital Ratio TTM 0.2 0.2 0.22 0.26 0.34
Total Ranking TTM # 3590 # 3655 # 3676 # 3654 # 3492
Seq. Current Liabilities TTM Growth 3.03 % 8.3 % 13.94 % 29.54 % 37.51 %
Seq. Current Assets TTM Growth 5.61 % -1.99 % -3.57 % -1.81 % -13.64 %


On the trailing twelve months basis In Spite of the decrease in Current Liabilities in the Q3 2024 to $21.14 millions, cumulative Working Capital Ratio remained unchanged at 0.2 below the Biotricity Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 209 other companies have achieved higher Working Capital Ratio than Biotricity Inc . While Working Capital Ratio overall ranking has improved so far to 3590, from total ranking during the twelve months ending second quarter 2024 at 3655.

Explain Working Capital Ratio
How much Current Assetss BTCY´s has?
What are BTCY´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 210
Healthcare Sector # 933
Within the Market # 3590


trailing twelve months Working Capital Ratio Statistics
High Average Low
3.06 0.79 0.17
(Jun 30 2022)   (Sep 30 2019)




Companies with similar Working Capital Ratio in the quarter ending Dec 31 2024, within Medical Equipment & Supplies Industry Working Capital RatioDec 31 2024 MRQ Current AssetsDec 31 2024 MRQ Current Liabilities
Predictive Oncology Inc   0.62 $ 2.226  Millions$ 3.593  Millions
Sharps Technology Inc   0.61 $ 3.174  Millions$ 5.186  Millions
Rosecliff Acquisition Corp I  0.57 $ 10.122  Millions$ 17.644  Millions
Seastar Medical Holding Corporation  0.55 $ 3.766  Millions$ 6.808  Millions
Sanuwave Health Inc   0.54 $ 18.397  Millions$ 34.045  Millions
National Vision Holdings Inc   0.53 $ 249.828  Millions$ 468.274  Millions
Dih Holding Us Inc   0.51 $ 24.158  Millions$ 47.324  Millions
Petvivo Holdings Inc   0.43 $ 1.262  Millions$ 2.936  Millions
Ir med Inc   0.38 $ 0.205  Millions$ 0.545  Millions
P3 Health Partners Inc   0.37 $ 184.140  Millions$ 496.415  Millions
Plus Therapeutics Inc   0.34 $ 5.259  Millions$ 15.551  Millions
Biotricity Inc   0.23 $ 4.861  Millions$ 21.141  Millions
Guided Therapeutics Inc   0.19 $ 1.197  Millions$ 6.155  Millions
Euda Health Holdings Limited  0.18 $ 0.763  Millions$ 4.141  Millions
Qhslab Inc   0.17 $ 0.421  Millions$ 2.407  Millions
Vycor Medical Inc   0.16 $ 0.702  Millions$ 4.497  Millions
Biosig Technologies Inc   0.15 $ 0.344  Millions$ 2.264  Millions
Yubo International Biotech Limited  0.14 $ 0.683  Millions$ 4.722  Millions
United Health Products Inc   0.12 $ 0.192  Millions$ 1.641  Millions
Mountain Crest Acquisition Corp V  0.10 $ 0.157  Millions$ 1.521  Millions
Stimcell Energetics Inc   0.10 $ 0.034  Millions$ 0.329  Millions
Invo Fertility Inc   0.07 $ 1.318  Millions$ 17.926  Millions
Vystar Corporation  0.07 $ 0.407  Millions$ 5.840  Millions
Bellevue Life Sciences Acquisition Corp  0.07 $ 0.455  Millions$ 6.719  Millions
Legacy Ventures International Inc  0.06 $ 0.001  Millions$ 0.016  Millions
Pavmed Inc   0.06 $ 2.164  Millions$ 34.933  Millions
Non Invasive Monitoring Systems Inc  0.05 $ 0.043  Millions$ 0.887  Millions

Date modified: 2025-04-11T08:54:34+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com